Adverse event reporting patterns of newly approved drugs in the USA in 2006: an analysis of FDA Adverse Event Reporting System data.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2013 AND VI 36 AND IP 11
Results: 7
1
2
Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1079, doi. 10.1007/s40264-013-0085-z
- By:
- Publication type:
- Article
3
Use of Acid-Suppressive Drugs in Pregnancy and the Risk of Childhood Asthma: Bidirectional Crossover Study using the General Practice Research Database.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1097, doi. 10.1007/s40264-013-0093-z
- By:
- Publication type:
- Article
4
Causes of Medication Administration Errors in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1045, doi. 10.1007/s40264-013-0090-2
- By:
- Publication type:
- Article
5
Identifying Associations between Maternal Medication Use and Birth Defects Using a Case-Population Approach: An Exploratory Study on Signal Detection.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1069, doi. 10.1007/s40264-013-0082-2
- By:
- Publication type:
- Article
6
Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1087, doi. 10.1007/s40264-013-0091-1
- By:
- Publication type:
- Article
7
Post-Approval Safety Issues with Innovative Drugs: A European Cohort Study.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1105, doi. 10.1007/s40264-013-0094-y
- By:
- Publication type:
- Article